|
Originally published In Press as doi:10.1074/jbc.M101537200 on April 6, 2001
J. Biol. Chem., Vol. 276, Issue 26, 23440-23449, June 29, 2001
Novel Sp Family-like Transcription Factors Are Present in Adult
Insect Cells and Are Involved in Transcription from the Polyhedrin Gene
Initiator Promoter*
Aruna
Ramachandran §¶,
Anjali
Jain§¶ ,
Puneeta
Arora**,
Murali Dharan
Bashyam §,
Udayan
Chatterjee  ,
Sudip
Ghosh§,
Veena K.
Parnaik**, and
Seyed E.
Hasnain §§§
From the Eukaryotic Gene Expression Laboratory,
National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi
110067, India, the § Laboratory of Molecular and Cellular
Biology, Centre for DNA Fingerprinting and Diagnostics, ECIL
Road, Nacharam, Hyderabad 500076, India, and the ** Centre for Cellular
and Molecular Biology, Uppal Road, Hyderabad 500007, India
Received for publication, February 19, 2001, and in revised form, April 3, 2001
 |
ABSTRACT |
We earlier documented the involvement of a
cellular factor, polyhedrin (polh) promoter-binding protein, in
transcription from the Autographa californica nuclear
polyhedrosis virus polh gene promoter. Sequences upstream of the polh
promoter were found to influence polh promoter-driven transcription.
Analysis of one such region, which could partially compensate for the
mutated polh promoter and also activate transcription from the
wild-type promoter, revealed a sequence (AcSp) containing a CACCC motif and a loose GC box resembling the binding motifs of the transcription factor Sp1. AcSp and the consensus Sp1 sequence (cSp) specifically bound factor(s) in HeLa and Spodoptera frugiperda
(Sf9) insect cell nuclear extracts to generate identical
binding patterns, indicating the similar nature of the factor(s)
interacting with these sequences. The AcSp and cSp oligonucleotides
enhanced in vivo expression of a polh promoter-driven
luciferase gene. In vivo mopping of these factor(s)
significantly reduced transcription from the polh promoter. Recombinant
viruses carrying deletions in the upstream AcSp sequence confirmed the
requirement of these factor(s) in polh promoter-driven transcription in
the viral context. We demonstrate for the first time DNA-protein
interactions involving novel members of the Sp family of proteins in
adult insect cells and their involvement in transcription from the polh promoter.
 |
INTRODUCTION |
The temporally regulated and hyperactivated polyhedrin
(polh)1 gene promoter of the
Autographa californica nuclear polyhedrosis virus
(AcNPV) belongs to the class of initiator promoters (1). The
primary determinant of polh promoter function is the 8-bp sequence
TAAGTATT, which encompasses the transcriptional start point and is
absolutely necessary for transcription initiation (2, 3). The minimal
polh promoter with all of the essential cis-acting elements
is defined as an 18-nucleotide region encompassing the initiator
sequence (4). A hexanucleotide sequence motif AATAAA, present within
the minimal promoter immediately 5' to the octanucleotide motif
TAAGTATT, has been demonstrated, along with the octamotif, to be the
target for binding of an unusual 30-kDa cellular transcription factor,
the polh promoter-binding protein (PPBP) (5). PPBP is a phosphoprotein
that binds with very high affinity and specificity and plays an
important role in transcription from this promoter (6), probably acting
as an initiator binding protein involved in the recruitment of
the transcription machinery (7). PPBP can also specifically bind to the
coding strand of the promoter (8) with increased affinity, compared
with the duplex promoter, thus maintaining the promoter at the
initiation point in a "melted" state allowing for increased rounds
of transcription.
Several AcNPV genes have been identified on the basis of
their trans-regulatory activity in transient expression
assays (9). Many of these, including a late gene that encodes a
putative protein with motifs conserved in RNA polymerases (10), have
been demonstrated to be activators of late and very late viral gene
expression by virtue of their effects on early events in the viral
infection cascade (9, 11). A virus-encoded four-component RNA
polymerase has been recently isolated from baculovirus-infected cells
(12). However, reconstitution of polymerase activity has not been
demonstrated in a cell-free system using the individually purified
proteins. A viral factor, VLF-1, has been shown to transactivate the
polh and p10 promoters, supposedly by interacting with the
3'-untranslated ("burst") sequences of these two very late
promoters (13). Thus far, except for the host factor PPBP, no other
protein that binds to the very late polh promoter and is directly
involved in transcription has been identified (6).
Sp1 was first discovered in mammalian (HeLa) cells as an activator of
transcription from the SV40 early promoter (14). Sp1 is part of a
larger Sp superfamily along with other members, sharing structural and
(sometimes) functional homology (reviewed in Refs. 15 and 16). Sp
family members bind to GC and GT box sequence motifs present in a
variety of cellular and viral promoters (17-19) via three highly
conserved C2H2 zinc finger motifs present in the C-terminal region of the protein (19). The N-terminal
glutamine-rich domains of Sp1, which are more divergent among the
family members, are essential for transcriptional activation function
(20, 21). Interaction between the glutamine-rich activation domains of
Sp1 and TATA-binding protein-associated cofactors plays an
essential role in the activation of TATA-less promoters (22). The
polyhedrin promoter also being a TATA-less initiator promoter prompted
us to investigate the requirement of Sp-like factors in transcription from this promoter.
In this report, we present the analyses of DNA sequences upstream of
the polh gene promoter and of the factors binding to identified
elements within these regions vis-à-vis their effect on transcription from the polh promoter in Spodoptera
frugiperda (Sf9) cells. Two regions that influence
transcription from the polh promoter were identified. One of these
regions has Sp1-binding motifs, can bind to probable Sp family-like
factors from Sf9 cells, and can complement the lack of
initiator promoter-based transcription. Sequestering in vivo
of the Sp family-like factor(s), which is distinct from PPBP,
significantly reduced transcription from the polh promoter, confirming
its involvement in polh promoter-driven transcription. Recombinant
viruses with deletions in the polh promoter upstream sequences
underscored the importance of these factor(s) in the viral context as
well and indicated that the enhancement of reporter gene expression was
not merely due to an enhancement of viral replication.
 |
EXPERIMENTAL PROCEDURES |
Cells and Virus--
Sf9 cells were cultured in
TNMFH (Life Technologies, Inc.) medium supplemented with 10%
fetal calf serum as described (23). Wild-type AcNPV strain
C6 was used for cell infection in transient expression assays.
Recombinant viruses were constructed by first cloning the polh-driven
luciferase gene with intact upstream sequences (pBacMAluc), an 800-bp
upstream deletion (pBac luc), or a deletion substituted by the AcSp
sequence (pBacAcSpluc) into the pBacPAK8 baculovirus transfer vector
(CLONTECH Laboratories Inc., Palo Alto, CA). Each plasmid was then transfected into Sf9 cells along with
BacPAK6 viral DNA (Bsu36I digest), and recombinant viruses
were constructed, purified, and titrated as per the manufacturer's
instructions (CLONTECH). Viral infection was
carried out with a multiplicity of infection of 10 of each
virus. To ascertain that equal amounts of viral DNA from the different
recombinants had entered the insect cells, equal amounts of the
reaction mixtures were fixed by dot-blot onto a nylon
membrane after the luciferase assay, followed by probing with the
luc cDNA and densitometric scanning.
Electrophoretic Mobility Shift Assays (EMSAs)--
Crude nuclear
protein extracts from Sf9 cells were prepared as described
(24). The consensus Sp1-binding oligonucleotide (cSp,
TATTCGATCGGGGCGGGGCGAGCC) was obtained commercially from Promega Inc.,
and the AcSp oligonucleotide (TAATGGGGTGTATAGTACCGCTGCGCATAGTC) was
chemically synthesized (Rama Biotechnology, Hyderabad,
India). Complementary synthetic oligonucleotides were
annealed and labeled with T4 polynucleotide kinase using
[ -32P]ATP. The binding reaction consisted of ~5 µg
of nuclear extract and 1 ng of labeled annealed oligonucleotide
(~104 cpm). For EMSAs, the crude nuclear extract was
incubated in the presence of the binding buffer (10 mM
Tris-HCl, pH 7.5, 0.7 mM Hepes-KOH, pH 7.7, 30 mM KCl, 1 mM EDTA, 50 mM EGTA, 0.8 mM MgCl2, 7 mM dithiothreitol, 1 mg/ml bovine serum albumin, 0.05% Nonidet P-40, 10% glycerol) and 1 µg of poly(dI-dC) for 10 min at 25 °C followed by incubation of
32P-labeled oligonucleotide for 20 min. The DNA-protein
complexes were resolved at 4 °C in an 8% (75:1
acrylamide/bisacrylamide) nondenaturing polyacrylamide gel in 0.5× TBE
buffer (0.045 M Tris borate, 0.001 M EDTA) at
200 V for 3 h. The gel was dried, covered with plastic wrap, and
exposed overnight to Hyperfilm MP (Amersham Pharmacia Biotech) at
70 °C. For competition analyses, a 400-fold excess of the
appropriate unlabeled, double-stranded DNA was added along with the
labeled DNA in the binding reaction. Radiolabeled oligonucleotide used
as a probe is marked by an asterisk in all EMSA figures. For
EMSAs using the pure Sp1 protein (Promega Inc.), 1 footprinting unit of
Sp1 (~25 ng of protein) was used in the binding reaction without the
addition of poly(dI-dC). The remaining conditions were identical
with all other EMSAs.
Plasmids and Constructs--
All DNA manipulations were carried
out as described (25). For the construction of pAJpolluc (Fig.
1) harboring the wild-type polh promoter,
the 92-bp EcoRV-BamHI promoter fragment was
obtained from the transfer vector pVL1393 (26) and cloned at the
HincII-BamHI site of plasmid pAJluc (a derivative
of pUC18 carrying the 1892-bp luc gene (26) ligated at the
BamHI site), placing it upstream from the luciferase
reporter gene. pAJmHluc (Fig. 2) carried
a synthetic 65-mer polh promoter with the mutated hexanucleotide motif
(CCGCCC instead of AATAAA) cloned at the
HindIII-SalI site of pAJluc driving the
luc gene. pKNluc (Fig. 1) was constructed by cloning the
luc gene at the BamHI site downstream of the polh promoter within the transfer vector pVL1393. A 2.77-kb
SalI-HindIII fragment from pKNluc was ligated at
the SalI-HindIII sites of pUC18 to obtain the
construct pKN603luc (Fig. 1).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Polyhedrin upstream sequences enhance
reporter gene expression. Schematic representation of the plasmid
constructs pAJpolluc, pKN603luc, and pKNluc. pKNluc has ~4 kb
upstream, and pKN603luc has ~766 bp upstream, whereas pAJpolluc has
no sequences upstream from the polh promoter. The luciferase activity
values of the constructs after being used in transient expression
assays are indicated on the right.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
The upstream ORF603 region partially
compensates for the mutated polyhedrin promoter. Schematic
representation of the plasmid constructs pAJpBS603-luc with the
unmutated hexamotif AATAAA, pAJpBS603mH-luc carrying the mutated
hexamotif CCCCCC in place of AATAAA, and pAJmHluc carrying the mutated
promoter with no upstream sequences, along with their respective
luciferase activity values.
|
|
pAcSp·pol·luc and pcSp·pol·luc vectors were constructed by
cloning the AcSp oligonucleotide and the cSp oligonucleotide,
respectively, at the PstI-HindIII site in
pAJpolluc and confirmed by dideoxy sequencing. pAR1 and pAR2
vectors used for the in vivo mopping experiments were
constructed by cloning the AcSp and cSp oligonucleotides, respectively,
at the PstI-HindIII site in pUC19.
pBacMAluc was constructed by cloning the luc gene at the
BamHI site of the pBacPAK8 transfer vector.
pAcSp·pol·luc and pAJpolluc were digested with PvuII and
SacI to release the promoter-luciferase cassette with and
without the AcSp oligonucleotide, respectively, and end-filled using
the Klenow fragment of Escherichia coli DNA polymerase I
(New England BioLabs, Beverly, MA). The AcSp-containing fragment was
cloned into the MluI-XhoI sites of pBacPAK8
(after end-filling the digested vector fragment first), whereas the
other PvuII-SacI fragment was cloned into the
MluI-SmaI site of pBacPAK8. The clones so
obtained were called pBacAcSpluc and pBac luc, respectively.
Site-directed Mutagenesis--
For site-directed mutagenesis
experiments, the 2.77-kb SalI-HindIII fragment
from pKNluc was cloned within the polylinker region of the 3.0-kb
phagemid pBS+ to generate the construct,
pAJpBS603-luc (Fig. 2). The plasmid construct
pAJpBS603-luc was transformed into competent TG1 cells and
infected with the phage M13KO7, and single-stranded template DNA was
isolated and used for site-directed mutagenesis using standard
protocols (25). The quality of the template was checked by sequencing
with a T7 primer. Five picomoles of a 24-mer oligonucleotide (CATCTCGCACCCCCCTAAGTATTT), spanning the region to be
mutated and harboring the mutated version of the hexamotif
(underlined), was phosphorylated with 5 mM ATP for 30 min
at 37 °C. It was annealed to the single-stranded DNA template
followed by extension and ligation reactions in the presence of Klenow
and T4 DNA ligase enzymes. The reaction mixture was transformed into
competent TG1 cells to generate pAJpBS603mH-luc (Fig. 2),
and the mutant clones were identified by colony hybridization using the
24-mer oligonucleotide as a probe. The mutation was confirmed by
dideoxy sequencing.
In Vivo Luciferase Expression Assays--
The expression of
luciferase in Sf9 cells transfected with the reporter
plasmids was carried out as described (27). Light emission was
monitored with a manual luminometer (model 1250; Bio-Orbit Oy, Turku,
Finland) over an integration period of 10 s. All of the
transfections were repeated, in duplicate, at least three times. To
ascertain that equal amounts of plasmid DNA from the different
constructs had entered the insect cells, equal amounts of the reaction
mixture after the luciferase assay were fixed by dot-blot on a
nylon membrane followed by probing with the luc cDNA and
densitometric scanning. All transfections included appropriate negative
controls, viz. mock-transfected Sf9 cells and
cells subjected only to viral infection without plasmid transfection.
In vivo mopping (28) was monitored on a Lumicount microplate
luminometer (Packard Instrument Company, Meriden, CT) according to the
manufacturer's instructions. For this, 2 µg of the reporter plasmid
was used (pAcSp·pol·luc or pcSp·pol·luc) with or without 18 µg of specific competitor (pAR1 or pAR2) or nonspecific competitor (pUC19).
UV Cross-linking--
The binding reaction was carried out as
described for the EMSAs, but after incubation with the labeled probes
the tubes were exposed to short-wave UV light for half an hour using a
hand-held UV monitor (model UVGL-58; UVP, Inc., San Gabriel,
CA), and the DNA-protein complexes were resolved as described
earlier (5).
DNase I Protection Assays--
A 140-bp PCR product was
generated using forward and reverse primers termed FPL and FPR,
corresponding to the coding and noncoding strands of AcNPV,
respectively, containing the AcSp motif approximately in the center of
the amplicon. The primer sequences are: FPL, TATGTATCTATCGTATAGAG, and
FPR, ACACACTCCGAAGAACTACC. 5 ng of pKN603luc was used as the template
for PCR. 200 ng of each primer was radiolabeled with T4 polynucleotide
kinase (New England BioLabs) and [ -32P]ATP and used
separately in a PCR reaction along with an equal amount of unlabeled
opposite primer to generate a radiolabeled coding or noncoding strand.
The PCR products were gel-purified and concentrated to a final volume
of about 100 µl. 2 µl was used to take Cerenkov counts in a
scintillation counter. About 25,000 cpm was used per reaction. The
DNase I reaction was carried out at ambient temperature as follows. The
binding reaction was carried out using 4 footprinting units (~100 ng)
of pure recombinant human Sp1 (Promega Inc.), as per the Sp1 EMSA
conditions in a volume of 40 µl followed by the addition of 40 µl
of a 5 mM CaCl2, 10 mM
MgCl2 mix. 30 s later, 1.3 µl of 1:3 diluted
RNase-free DNase I (Promega Inc.) was added and incubated for 2 min,
followed by the addition of 90 µl of stop solution (200 mM NaCl, 30 mM EDTA, 1% SDS). The DNA was
extracted twice with an equal volume of 1:1 phenol:chloroform, and
glycogen was added to a final concentration of 20 mg/ml; the mixture
was precipitated with ethanol at 70 °C for 3 h, washed
twice with 70% ethanol, and resuspended in 5 µl of sequencing
loading buffer containing 90% formamide. Control DNase I reactions
were carried out under identical conditions except that no protein was
added. A + G ladders were generated for both strands using formic acid
and piperidine according to the method of Maxam and Gilbert (29). Equal
counts of all reactions were loaded onto an 8% denaturing acrylamide
gel containing 1× TBE and 8 M urea and resolved at 75 watts for 2 h, after which the gel was fixed for 10 min in 10%
acetic acid and 20% methanol, covered with plastic film, dried under
vacuum, and subjected to autoradiography at 70 °C.
 |
RESULTS |
A 4-kb Sequence Upstream from the Polyhedrin Promoter Modulates
Polyhedrin Basal Transcription--
A series of progressive Bal31
exonuclease deletion constructs of pNEluc (30), encompassing the
complete 4-kb sequence upstream from the polh gene promoter within the
AcNPV EcoRI-I fragment, were generated and used
in luciferase-based transient expression assays (31). This deletion
analysis identified two regions, region I and region II, spanning map
units 0-1.5 and 2.5-3.12, respectively, on the EcoRI
"I" fragment of the viral genome. Deletion of these sequences
resulted in a drastic reduction of reporter gene expression in
comparison with the original pNEluc plasmid construct (31). Having
identified the approximate boundaries of upstream sequences influencing
polh promoter activity, three clones with defined upstream sequences
were constructed and used in luciferase-based transient expression
assays to evaluate the effect of such cis-acting sequences
on the minimal promoter-driven expression (Fig. 1). pAJpolluc displayed
basal luciferase expression, pKN603luc consistently showed 2-3-fold
increased expression above pAJpolluc, and pKNluc displayed about a
20-fold increase in basal expression. The results complement our
earlier observations that the 4-kb sequence upstream from the polh
promoter does contain sequence elements that enhance basal polh expression.
Region II Can Compensate for the Absence of the Hexanucleotide
Motif within the Polyhedrin Initiator Promoter--
Having
demonstrated the stimulatory role of the upstream 766-bp sequence on
reporter gene expression from the polh basal promoter, we evaluated the
importance of this sequence vis-à-vis the essential determinants of this promoter. We previously showed that the hexamotif (AATAAA) present within the initiator region of the polyhedrin promoter
is critical for PPBP binding (5, 8) and subsequent expression from this
promoter (6). To further extend this observation, the expression of
luciferase in pAJmHluc was compared with pAJpBS603mH-luc. Luciferase expression from the construct pAJpBS603-luc
(carrying an intact hexamotif and the ORF603 sequence) was used as a
control. pAJpBS603mH-luc exhibited reduced luc
expression compared with pAJpBS603-luc, but this activity
was still significantly higher than pAJmHluc, which did not
carry the ORF603 upstream sequence. In pAJmH luc (where the hexamotif
was mutated without the presence of any upstream sequences),
luciferase activity above the background cut-off limit of 10 mV was not
detected. These data demonstrate that the hexamotif is critical for
promoter function; however, its absence can be compensated, albeit to a
lesser extent, by sequence elements within the upstream region II
containing ORF603.
An Sp1-like GC Box and CACCC Motif Is Present within
ORF603--
To arrive at the sequence determinants involved in
rescuing basal transcription in the presence of the mutant polh
initiator, the ORF603 sequence was scanned for binding motifs specific
for known transcription factors. A region from 438 to 468, termed as AcSp, which was GC-rich in the otherwise AT-rich baculovirus genome,
was identified within this sequence stretch (Fig. 1). Analysis of this
sequence showed some similarity to the GC-rich sequences that bind the
general transcription factor Sp1, which is known to play an important
role in the initiator-mediated mechanisms of transcription (32-34).
Comparison of the AcSp sequence with the Sp1-binding motif consensus
(defined by comparing sequences from 36 sources) (35, 36),
(G/T)(G/A)GGCG(G/T)(G/A)(G/A)(G/T), identified two putative Sp
family binding motifs, TACCGCTGC, with about 70% homology with the
consensus GC box, and a consensus CACCC motif, which is bound by some
Sp family proteins. This analysis and the fact that the polh promoter
is an initiator promoter pointed to the possibility of the involvement
of an Sp1-mediated mechanism in polh promoter regulation.
An Sp-like Host Factor(s) Is Present in Insect Cell Nuclear
Extracts--
EMSAs were carried out to ascertain the presence of
trans-acting factor(s) in Sf9 cells that could
bind to the AcSp motif. The oligonucleotides corresponding to the cSp
sequence and the AcSp sequence were used as probes in EMSAs with
nuclear extracts prepared from uninfected and AcNPV-infected
Sf9 cells (24). It is evident that at least one complex of
similar mobility is obtained with both uninfected (Fig.
3a, lanes 3 and
4) and infected (lanes 5 and 6)
nuclear extracts using both probes. In addition, a faster mobility
complex is also evident under these binding conditions with uninfected
cell nuclear extract (lanes 3 and 4) with both of
the probes. These results demonstrate the presence of a host factor(s)
in the insect cell nuclear extracts that can bind to the Sp1-like
sequence motif present within ORF603 of region II (AcSp) as well as
cSp.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 3.
a, an Sp family-like factor(s) is
present in insect cell nuclear extracts. An EMSA using oligonucleotides
carrying the cSp and AcSp sequences is shown. Sf9 nuclear
extracts from uninfected (u) cells (lanes 3 and
4) or virus-infected (i) cells (lanes
5 and 6) were used in binding reactions. b,
cSp can effectively compete with AcSp for binding to the Sp family-like
insect factor(s). An EMSA with the AcSp sequence motif is shown.
Lane 1, free probe without any protein extract; lane
2, binding in the presence of Sf9 nuclear extract;
lanes 3, 4, and 5, binding in the
presence of cold competitors AcSp, cSp, and pUC18 DNA, respectively.
c, AcSp competes with cSp for binding to the
Sf9 Sp family-like factor(s). An EMSA was carried out
using cSp as a probe. Lane 1, free probe; lanes
3-6, binding in the presence of Sf9 nuclear extract
alone (lane 3) or in the presence of unlabeled cSp
(lane 4), AcSp (lane 5), and pUC18 DNA
(lane 6). Lane 2 shows binding with AcSp as a
probe for comparing the nature of the complexes obtained with both
probes. d, HeLa Sp family factor(s) bind to the AcSp
sequence. An EMSA using HeLa (lanes 5-12) and
Sf9 (lanes 3 and 4) nuclear extracts.
AcSp probe was used in the absence of any extract (lane 1)
or with Sf9 nuclear extract (lane 3) and HeLa
cell nuclear extract (lane 5) is shown. Lanes 2,
4, and 6 show the corresponding results using the
cSp probe. Lanes 7 and 8 show competition with
homologous cold AcSp and heterologous cSp competitors, respectively.
Lanes 9 and 10 similarly show competition with
homologous cold cSp and heterologous AcSp competitors, respectively.
Competition using pUC18 is shown in lanes 11 and
12. e, the HeLa and Sf9 Sp
family-like protein(s) require zinc for DNA binding. An EMSA performed
with labeled AcSp and cSp probes is shown. Lanes 1 and
2, free AcSp and cSp probes, respectively.
Binding of both probes with Sf9 and HeLa cell nuclear
extract is shown in lanes 3 and 4 and lanes
7 and 8, respectively. Lanes 5 and
6 show binding in the presence of 20 mM OP using
Sf9 nuclear extract, whereas lanes 9 and
10 represent binding of the two probes in the presence of
HeLa cell nuclear extract and 20 mM OP.
|
|
The Consensus Sp1 Sequence Can Effectively Compete with the AcSp
Sequence for Binding to Sp-like Factor(s) Present in Sf9
Cells--
The Sp-like complex generated with uninfected
Sf9 nuclear extract was subjected to cross-competition
analyses in EMSAs using authentic Sp1-binding motifs. Fig.
3b shows AcSp binding to (uninfected) Sf9 nuclear
extract in the absence of any cold competitor (lane 2) and
in the presence of AcSp, cSp, and pUC18 cold competitors (lanes
3, 4, and 5, respectively). It is
interesting to note that in certain instances the consensus Sp1
sequence can compete even better than the homologous competitor for the
AcSp probe. This is understandable because the factor(s) present could
well have a higher affinity for the Sp1 cognate sequence defined by cSp rather than the AcSp sequence. pUC18 did not compete for the binding, further pointing to the specificity of the complexes formed.
The AcSp Sequence Can Compete with the cSp
Oligonucleotide--
Having shown that the Sf9 Sp-like
factor(s) binding to the AcSp sequence can be effectively competed out
by the consensus Sp1 sequence, the reverse experiment was carried out
using radiolabeled cSp oligonucleotide as a probe in EMSAs. It is
apparent that the binding (Fig. 3c, lane 3) was
abolished after homologous cold competition (lane 4), but
when cold AcSp was used as a competitor (lane 5), the
complex with reduced mobility was competed out rather inefficiently.
This is further evident after comparison of the competition with the
nonspecific competitor pUC18 (lane 6). Interestingly, the
complex of higher mobility (lower shift) was better competed. Lanes 1 and 3 show cSp mobility without and with
the nuclear extract, respectively. Lane 2 shows the binding
of AcSp with the nuclear extract to compare the similar nature of the
shifts obtained with both of the probes.
The Sp Family Factor(s) Present in HeLa Cell Nuclear Extract Also
Binds to the AcSp and cSp Sequences--
The data presented above
established the presence of factor(s) present in Sf9 cells,
which specifically bind to AcSp as well as to the Sp1 consensus
sequence, indicating that the insect factor(s) behaved like the Sp
family of proteins in terms of cognate sequence recognition and
cross-cold competitions. It was therefore pertinent to investigate
whether the Sf9 Sp family complex is the same as the well
characterized Sp family of factors present in HeLa cells. Fig.
3d shows the binding of AcSp and cSp with Sf9 and
HeLa nuclear extracts. Lanes 3 and 5 show the
binding of factor(s) present in Sf9 and HeLa extracts to
radiolabeled AcSp, respectively. Lanes 4 and 6 show the binding of similar factors present in Sf9 and HeLa
extracts to the cSp probe. Interestingly, a similar complex is obtained
using both probes and either of the extracts. The HeLa cell factor(s)
binds to the AcSp oligonucleotide to generate a complex with reduced
intensity as compared with that obtained with cSp (compare lane
5 with lane 6), possibly because the AcSp sequence is
not 100% identical to the Sp1 consensus. The fact that the HeLa
extracts containing the Sp family of factors generate a complex similar
to that of Sf9 extract with either of the probes directly
points to the possibility of Sf9 cells also harboring Sp
family-like transcription factors. Interestingly, the competition pattern seen with the HeLa extracts mirrors that seen with
Sf9 extracts (shown earlier in Fig. 3, b and
c) in that cSp can compete very efficiently with the AcSp
probe, but AcSp competitor cannot compete as efficiently as cSp for
binding to the cSp probe (compare lane 8 with lane
10). Homologous cross-cold competitions expectedly abolished
binding with both probes (lanes 7 and 9), whereas
a nonspecific competitor, pUC18, did not affect binding with either probe (lanes 11 and 12). These results
convincingly demonstrate that whereas Sf9 cell nuclear
extracts harbor Sp family-like transcription factors, the corresponding
factors from HeLa cells can also bind to the viral AcSp motif.
The Sp Family-like Proteins Both in HeLa and Sf9 Nuclear
Extracts Require Zinc for Binding to the Cognate Nucleotide Sequence
Motif--
Binding of the mammalian Sp family proteins to DNA involves
zinc fingers (19). We investigated the requirement of zinc by the
Sf9 Sp family-like factor(s) with regard to its interaction with the cSp or AcSp motif. Inhibition of binding of these factors from
the HeLa cell nuclear extract to cSp and AcSp in the presence of
1,10-o-phenanthroline (OP), a known chelator of zinc, was
used as a reference. In an EMSA where OP is added to the reaction
mixture, binding of the Sf9 Sp-like factor(s) is seen to be
affected (Fig. 3e). The binding of both AcSp and cSp probes
with Sf9 nuclear extract (lanes 3 and
4) was significantly reduced by the addition of 20 mM OP (lanes 5 and 6), and the
binding with the HeLa nuclear extract (lanes 7 and
8) was completely abolished (lanes 9 and 10) under similar conditions. The inhibition of binding
exhibited by HeLa cell Sp family factors in the absence of zinc is
consistent with our knowledge of the Sp family proteins; the same
effect seen for the Sf9-derived Sp-like factor(s)
strengthens the Sp family-like characteristics of the Sf9 factor(s).
UV Cross-linking Experiments of the Sf9 Sp Family-like
Protein(s) Binding to AcSp and cSp Reveal Identical
Complexes--
Fig. 4 shows UV
cross-linking experiments carried out with 0.5 µg of Sf9
nuclear extract and AcSp and cSp probes. Lanes 1-3 represent controls to rule out any nonspecific interactions that may be
observed. Lanes 4 and 5 show cross-linking with
the AcSp and cSp probes, respectively, to generate DNA-protein
complexes of similar molecular sizes.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
UV cross-linking with cSp and AcSp
probes. Lanes 1 and 2 show AcSp probe
without and with Sf9 nuclear extract, respectively, without
UV exposure. Lane 3 shows free AcSp probe after UV exposure.
Lanes 4 and 5 show proteins cross-linked to the
AcSp and cSp probes, respectively, using Sf9 nuclear
extract.
|
|
The Sf9 Sp Family-like Factor(s) Is Distinct from
PPBP--
We previously demonstrated the requirement of host factors
in regulating polh promoter-driven transcription (5, 6, 8, 24, 28, 37,
38). It is therefore important to show that the Sp family-like
factor(s) present in Sf9 cells described above is distinct
from the well characterized PPBP. Fig. 5
shows the binding of PPBP to the polh promoter B domain oligonucleotide (5) carrying the basal promoter determinants. The complex generated by
the binding of PPBP, present in uninfected Sf9 nuclear
extract, to the labeled B domain oligo (lane 2) can be
specifically competed out only by the presence of homologous cold
competitor (lane 3) and not with cSp (lane
4) or AcSp (lane 5), indicating that the Sp-like
factor(s) present in Sf9 extract is distinct from the host
factor PPBP involved in polh gene transcription.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 5.
The Sf9 Sp-like factor(s) is
distinct from PPBP. EMSA was carried out with labeled polyhedrin
promoter B domain (lane 1), Sf9 nuclear extract
(NE-Sf9), and competitions with a 25-fold excess of
unlabeled B domain (lane 3), cSp (lane 4), and
AcSp (lane 5) oligonucleotides.
|
|
Recombinant Human Sp1 Protein Binds Weakly to the AcSp Sequence in
EMSAs--
To substantiate the authenticity of the cSp probe, EMSAs
were carried out with pure recombinant human Sp1 (Fig.
6a). cSp expectedly binds to
pure hSp1 (lane 6) under the reaction conditions used. However, the mobility of the shift is less than that with the Sf9 extract (lane 5), indicating that the insect
proteins binding to cSp are not classical Sp1 but a different member of
the Sp family. AcSp probe also shows a weak shift with pure Sp1
(lane 3) as compared with the Sf9 extract
(lane 2). These results demonstrate that the AcSp sequence
is recognized by the human Sp1 protein and that the insect cell Sp
factor(s) is different from classical Sp1.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
a, recombinant human Sp1 binds weakly to
the AcSp sequence in EMSAs. Binding of radiolabeled AcSp (lanes
1-3) and cSp (lanes 4-6) oligonucleotides with pure
recombinant human Sp1 protein (rhSp1, lanes 3 and
6) and Sf9 nuclear extract
(NE-Sf9, lanes 2 and 5) is
shown. b, Sp1 protein binds to the AcSp noncoding strand.
Lanes 1-3 represent DNase I protection analysis using the
radiolabeled 140-bp coding strand of the AcNPV genome containing the AcSp
sequence approximately in the center. Lane 1 depicts the A + G sequencing ladder. Lanes 2 and 3 show DNase I
treatment in the absence and the presence, respectively, of recombinant
human Sp1 (rhSp1) protein. Lanes 4-6 represent
corresponding lanes using the labeled noncoding strand. The boundaries
of the AcSp sequence are marked by arrows on both labeled
strands.
|
|
Sp1 Protein Binds to the AcSp Noncoding Strand--
DNase I
footprinting assays were carried out (Fig. 6b) using a
140-bp viral polh upstream region as a probe containing the AcSp
sequence motif in the center and pure Sp1 protein (Promega Inc.). The
coding strand does not show any protection in the AcSp region. However,
practically the entire AcSp sequence is significantly protected on the
noncoding strand, confirming the ability of the AcSp element to bind to
members of the Sp family. The boundaries of the AcSp sequence are
marked by arrows.
The Insect Sp Family-like Protein(s) Is Involved in the Enhancement
of Reporter Gene Expression in Vivo--
Transient transfection
experiments were carried out using the plasmids pAcSp·pol·luc,
pcSp·pol·luc, and pKN603luc (described under "Experimental
Procedures"). It was observed that all three constructs enhanced
luciferase expression to about the same extent (data not shown),
indicating that AcSp is perhaps the critical motif involved in the
transcription enhancement exhibited by the upstream ORF603 sequence.
In vivo mopping experiments (28) were carried out using
pAcSp·pol·luc and pcSp·pol·luc as reporters in the presence of
varying amounts of competitor plasmids. pUC19 served as a nonspecific
competitor, whereas pAR1 (AcSp construct) and pAR2 (cSp construct)
were used as specific competitors (described under
"Experimental Procedures"). The results (Fig.
7) demonstrate a dramatic drop in
reporter expression in the presence of competitor plasmid (pAR1 or
pAR2; second, third, fifth, and
sixth lanes). The nonspecific competitor pUC19 failed to
show a similar effect (first and fourth lanes).
The seventh and eighth lanes depict the
luciferase activity obtained with 20 µg of pAcSp·pol·luc and pcSp·pol·luc, respectively. These results indicate that the
transcription enhancement is indeed due to the involvement of the Sp
family-like factor(s) and not merely a function of the cis
sequence.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 7.
Mopping of the insect Sp family protein(s)
in vivo causes a reduction in polh promoter-driven
reporter gene expression. Luciferase expression levels using 20 µg of pAcSp·pol·luc (seventh lane) and
pcSp·pol·luc (eighth lane) plasmids after transfection
into Sf9 cells were compared in the presence of specific or
nonspecific co-transfected competitor plasmids. The first
and fourth lanes show luciferase expression using the
reporter plasmids pAcSp·pol·luc and pcSp·pol·luc, respectively,
with pUC19 used as a nonspecific competitor. The second and
third lanes depict luciferase expression using
pAcSp·pol·luc in the presence of competitor plasmids pAR1 or pAR2,
respectively. Likewise, the competition with pAR1 or pAR2 using
pcSp·pol·luc as reporter is shown in the fifth and
sixth lanes, respectively. The ninth lane depicts
AcNPV infection carried out in the absence of any
transfected plasmid.
|
|
The AcSp Sequence Is Functionally Significant in the Viral
Context--
Three viruses were constructed carrying the luciferase
reporter driven by the polh promoter with varying upstream sequences (Fig. 8a) to establish the
requirement of the AcSp motif in the viral context. vMAluc has all of
the upstream sequences intact including the upstream hr1 enhancer (28),
v luc has an immediate upstream 800-bp deletion, and vAcSpluc has the
800-bp deletion replaced with the AcSp oligonucleotide. Luciferase
activity was assayed after infecting Sf9 cells at a
multiplicity of infection of 10 (Fig. 8b). Uninfected cells
(Sf9) or cells infected with wild-type AcNPV
virus showed no luciferase expression, whereas infection with v luc
showed extremely low expression. Infection with vAcSpluc increased
luciferase expression 1000-fold compared with the construct carrying no
AcSp sequence (v luc), and infection with vMAluc, which contains all
upstream sequences intact, showed a 10,000-fold increase in luciferase
activity as compared with v luc. Fig. 8c shows the
dot-blot analysis of cells infected in duplicate by the three
recombinant viruses probed with the radiolabeled luc gene.
Densitometric scanning revealed that the levels of infection of the
three viruses were comparable. It is therefore clear that the
identified AcSp sequence functions in vivo in the viral
context.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 8.
The AcSp motif is necessary for transcription
enhancement from the viral polh promoter in vivo.
a, schematic representation of the recombinant baculoviruses
vMAluc, v luc, and vAcSpluc carrying the polyhedrin promoter-driven
luciferase gene, with varying sizes of upstream sequences.
b, luciferase levels recorded in Sf9 cells or
after infection with a multiplicity of infection of 10 for
AcNPV or recombinant viruses, assayed 65 h.p.i.
c, dot-blot of cells infected with v luc, vAcSpluc, and
vMAluc recombinant viruses at 65 h.p.i. Duplicate wells were
dotted without dilution or after 1:10 dilution. The negative controls
were uninfected cells (Sf9) and wild-type virus-infected
cells (AcNPV) dotted undiluted in duplicate. The
luc gene was used as a probe.
|
|
 |
DISCUSSION |
A battery of viral proteins have been implicated in transcription
from the polh promoter (9-12, 39) either directly or because of a
replication effect. However, reports from our laboratory have brought
into focus the categoric involvement of host proteins as well in this
process (5, 6, 28, 37). PPBP has been shown to be involved in binding
to the polh promoter and in transcription from it, and another protein,
hr1BP, binds to the hr1 viral enhancer sequence to bring about
transcription enhancement. Our report on the presence of host Sp
family-like proteins, while documenting for the first time the
existence of novel members of this family in adult insect cells, also
confirms their functional relevance in transcription from the polh promoter.
Region II, which enhances basal transcription, contains an open reading
frame, ORF603, encoding a putative 201-amino acid protein product.
However, the enhancement is not mediated through its protein product as
conclusively demonstrated by deletion experiments (40) within this
region. The enhancement caused by the region II sequence therefore
pointed to the possibility of this sequence per se being
essential and not the putative protein product. We identified a
nucleotide sequence stretch, named AcSp, within the ORF603 that
resembled the motifs recognized by the cellular transcription factor Sp1.
Sp1, the first member of the Sp superfamily to be isolated and
characterized, has been found to recognize asymmetric GC and GT boxes
present in a wide variety of cellular and viral promoters (41). A
comparison of 36 different binding sites revealed a range of binding
affinities, differing by at least 10-20-fold, with individual binding
sites displaying a remarkable degree of sequence variation (35, 36,
41). The AcSp sequence within ORF603 of region II has a close
resemblance to the Sp1 consensus sequence and could bind to Sp
family-like proteins in the Sf9 and HeLa cell nuclear
extracts. Further, both the HeLa and insect proteins binding to the
AcSp and consensus Sp sequences required zinc for DNA binding,
highlighting the Sp-like characteristics of the Sf9 factor(s).
Sp1 has been purified from human T cells, placental tissue, and from
several other organisms like mouse, rat, chicken, etc. The human
placenta-derived Sp1 is found to be ~40 kDa (42). The molecular size
of the insect Sp family-like factor(s) appears to be around 60 or 90 kDa. The ~90-kDa protein correlates well with the known molecular
mass range of the Sp family (~95-105 kDa), whereas the
~60-kDa protein could reflect the known size heterogeneity displayed
by these factors (42). It is evident that the Sf9 factor(s)
binding to AcSp and cSp does not represent classical Sp1; indeed, pure
Sp1 protein binds extremely weakly to AcSp in EMSAs and has a different
mobility from the insect protein-DNA complex (Fig. 6a).
However, the AcSp sequence is capable of binding to pure Sp1 as
revealed by DNase I footprinting analysis (Fig. 6b). The
Sp1-AcSp complex may be prone to dissociation under the conditions used
for study, a problem that can be circumvented by carrying out DNase I
protection analyses where the interaction need be stable only for a
short time in solution before DNase I treatment. We observed no
supershifting or immunodepletion with anti-Sp1, anti-Sp3, or anti-Sp4
antibodies (data not shown). It is therefore apparent that although
this protein(s) is a member of the Sp family, as observed by its
recognizing an Sp-related sequence and demonstrating a requirement for
zinc for DNA binding, it is not Sp1.
This particular family of zinc finger proteins is one of the most
diverse and populous known (15, 16), given the steady flow of reports
documenting the presence of new and related members in a wide range of
eukaryotic systems. A recent report even offers evidence of functional
Sp1-binding sites in a basidiomycete fungus, Cryptococcus
neoformans (43). Other proteins that belong to the Sp superfamily
include the Krüppel-like factors, including BKLF, EKLF, IKLF,
etc. (15, 16); the BTEB proteins (BTEB1 and 2); CPBP proteins (CPBP,
Zf9, UKLF); TIEG (TIEG 1 and 2) proteins (15, 16); and the
protein products of the huckebein (hkb) (44), buttonhead
(bth) (45), and D-Sp1 (46) genes that are expressed in Drosophila embryos only during the blastoderm
stage. There are no reports, however, of such factors being present in adult insect tissue (20, 47, 48).
Sp2, Sp3, and Sp4, the other closely related members of the Sp1
subgroup of the Sp family of proteins (49-51), are structurally similar, recognizing similar but not always identical GT- and GC-rich
sequences, and act as activators or repressors of transcription depending on their intrinsic properties and the promoter context (50,
52). Sp1 is known to cross-talk with a large number of cellular as well
as viral transactivators. The Sp family members are also known in
several instances to bind concomitantly and synergistically (20) to
sequences upstream from various promoters, thereby effecting
transcriptional activation (53) or repression (52) in a
context-dependent fashion.
Basal levels of polh promoter expression are increased in the presence
of sequences containing the consensus Sp1 or the AcSp sequence. Our
findings show both an enhancement (in the case of an intact initiator)
and a rescue of transcription (in the presence of a mutant
initiator) with upstream regions of the polh promoter carrying the AcSp
or cSp motifs. In the bovine papillomavirus E2-responsive promoters,
the TATA box or the initiator can be functionally replaced by
Sp1-binding sites (32). It is known that human TATA-binding
protein-associated factor, hTAFII130 (54), and its
Drosophila homolog, dTAFII110 (55), interact
with the glutamine-rich activation domains of human Sp1, suggesting a
role for these interacting proteins as direct co-activator targets for
Sp1. Sf9 cells are known to contain TBP, but no
studies have been carried out on TATA-binding protein-associated
factors present in Sf9 cells. By comparison with the human
and Drosophila models, it is possible that the Sp
family-like proteins observed by us may bring about transcription
enhancement in an analogous fashion. However, basal transcription from
the polh promoter is mediated by a viral RNA polymerase (12), and no
cellular factors to date have been identified that take part in
this process; the only exception to this was PPBP (6), which was
identified in our laboratory as a promoter-binding protein that is
critical for polh transcription. Our observation that mutations in the
polh promoter and the crucial PPBP-binding motifs are partially
restored if region II containing the AcSp sequence is present brings
into focus the important role of cellular factors in basal transcription.
Furthermore, mopping of the Sp family trans-acting factors
significantly reduces transcription from the polh promoter, pointing to
the necessity of this DNA-protein interaction in transcription activation. The use of recombinant baculoviruses provides definitive evidence that the AcSp sequence is required for hypertranscription from
the polh promoter in vivo. The deletion of an upstream
800-bp region in v luc practically abolished luciferase gene
expression, whereas the substitution of the AcSp sequence motif
(vAcSpluc) increased expression 1000-fold. The virus with completely
intact upstream sequences (vMAluc) increased transcription a further 10-fold. Several viral proteins have been shown to play a role directly
or indirectly in activated transcription from the polh promoter. The Sp
family-like proteins observed by us are the first instance of such
factors having a role in transcription in this system.
Interestingly, the increase in transcription using AcSp-carrying
plasmids in transient transfections was merely 2-3-fold in contrast to
the dramatic 1000-fold increase with the corresponding virus. On
further analysis, however, our observations proved to be in concordance
with recent models proposing that enhancer-binding elements acting from
a promoter-distant position require interaction with proximal sequences
near the vicinity of the TATA box to recruit RNA polymerase (56). In
this case, the initiator element possibly requires the Sp family-like
proteins (apart from other factor(s) such as PPBP) to help recruit the
polymerase. This may explain why even when upstream enhancer elements
are present, such as the hr enhancer sequences, the absence of
promoter-proximal sequences (as in v luc) prevents the efficient
recruitment of the RNA polymerase, thereby reducing transcription
enhancement. Densitometric scanning of the dot-blot of viral DNA after
infection and luciferase assay showed no significant difference in the
amounts of viral DNA, confirming that the enhancement of transcription
by the AcSp sequence was not merely due to an increase in the
replication of the virus.
Host factors are increasingly finding importance in regulating
transcription from baculovirus very late promoters (5, 6, 8, 24, 27,
28, 36, 37, 57, 58). In addition to PPBP, we have shown that another
host factor hr1BP binds to the hr1 enhancer sequence (27) and is
involved in hr1-mediated enhancement of transcription from the polh
promoter (28). Our observations on an unusual viral sequence
element-binding novel Sp family factor(s) in adult Sf9 cells
to regulate expression of a gene crucial for baculovirus survival in
the environment highlight a new facet of the mechanisms governing
transcription from the viral polh promoter. Studies are in progress to
further characterize the AcSp-binding factor(s) and elucidate in
greater detail their role in transcription. Given that the polh
promoter is a TATA-less initiator promoter coupled with the known
involvement of members of the Sp family of proteins in
initiator-mediated transcription (22), our results establish a vital
link between the insect Sp family-like proteins and regulation of
baculovirus polyhedrin-initiator transcription.
 |
ACKNOWLEDGEMENTS |
We thank all members of the Hasnain
laboratory for helpful discussions and Drs. Sandip Basu, Satyajit Rath,
and Yash Vaishnav for critical comments. We acknowledge the assistance
of Dr. Vijay Kumar in site-directed mutagenesis, Dr. Narendra Tuteja
for providing HeLa cell nuclear extracts, and Dr. K. Natarajan for the
pKN603luc and pKNluc constructs.
 |
FOOTNOTES |
*
This work was supported by Department of Science and
Technology Grant SP/SO/D-45/95 (to S. E. H.) and by core
support from the Department of Biotechnology, Government of India to
National Institute of Immunology and Centre for DNA Fingerprinting and Diagnostics.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
These authors contributed equally to this work.
Present address: Howard Hughes Medical Inst., UCLA School of
Medicine, Los Angeles, CA 90024-1662.

Present address: Dept. of Molecular Biology, Scripps Research
Inst., 10550 N. Torrey Pines Rd., La Jolla, CA 92037.
§§
To whom correspondence should be addressed. Tel.:
91-40-7155604; Fax: 91-40-7155610; E-mail:
ehtesham@www.cdfd.org.in.
Published, JBC Papers in Press, April 6, 2001, DOI 10.1074/jbc.M101537200
 |
ABBREVIATIONS |
The abbreviations used are:
polh, polyhedrin;
AcNPV, Autographa californica nuclear
polyhedrosis virus;
bp, base pair(s);
PPBP, polh promoter-binding
protein;
EMSA, electrophoretic mobility shift assay;
kb, kilobase pair(s);
PCR, polymerase chain reaction;
ORF, open reading frame;
OP, 1,10-o-phenanthroline.
 |
REFERENCES |
| 1.
|
Smale, S. T.,
and Baltimore, D.
(1989)
Cell
57,
103-113
|
| 2.
|
Ooi, B. G.,
Rankin, C.,
and Miller, L. K.
(1989)
J. Mol. Biol.
210,
721-736
|
| 3.
|
Rankin, C.,
Ooi, B. G.,
and Miller, L. K.
(1988)
Gene (Amst.)
70,
39-50
|
| 4.
|
Morris, T. D.,
and Miller, L. K.
(1994)
Gene (Amst.)
140,
147-153
|
| 5.
|
Burma, S.,
Mukherjee, B.,
Jain, A.,
Habib, S.,
and Hasnain, S. E.
(1994)
J. Biol. Chem.
269,
2750-2757
|
| 6.
|
Ghosh, S.,
Jain, A.,
Mukherjee, B.,
Habib, S.,
and Hasnain, S. E.
(1998)
J. Virol.
72,
7484-7493
|
| 7.
|
Ptashne, M.,
and Gann, A.
(1997)
Nature
386,
569-577
|
| 8.
|
Mukherjee, B.,
Burma, S.,
and Hasnain, S. E.
(1995)
J. Biol. Chem.
270,
4405-4411
|
| 9.
|
Todd, J. W.,
Passarelli, A. L.,
and Miller, L. K.
(1995)
J. Virol.
69,
968-974
|
| 10.
|
Passarelli, A. L.,
Todd, J. W.,
and Miller, L. K.
(1994)
J. Virol.
68,
4673-4678
|
| 11.
|
McLachlin, J. R.,
and Miller, L. K.
(1994)
J. Virol.
68,
7746-7756
|
| 12.
|
Guarino, L. A.,
Xu, B.,
Jin, J.,
and Dong, W.
(1998)
J. Virol.
72,
7985-7991
|
| 13.
|
Yang, S.,
and Miller, L. K.
(1999)
J. Virol.
73,
3404-3409
|
| 14.
|
Dynan, W. S.,
and Tjian, R. T.
(1983)
Cell
35,
79-87
|
| 15.
|
Turner, J.,
and Crossley, M.
(1999)
Trends Biochem. Sci.
24,
236-241
|
| 16.
|
Philipsen, S.,
and Suske, G.
(1999)
Nucleic Acids Res.
27,
2991-3000
|
| 17.
|
Benoist, C.,
and Chambon, P.
(1981)
Nature
290,
304-310
|
| 18.
|
Jackson, S. P.,
MacDonald, J. J.,
Lees-Miller, S.,
and Tjian, R.
(1990)
Cell
63,
155-165
|
| 19.
|
Kadonaga, J. T.,
Carner, K. R.,
Masiarz, F. R.,
and Tjian, R.
(1987)
Cell
51,
1079-1090
|
| 20.
|
Pascal, E.,
and Tjian, R.
(1991)
Genes Dev.
5,
1646-1656
|
| 21.
|
Su, W.,
Jackson, S.,
Tjian, R.,
and Echols, H.
(1991)
Genes Dev.
5,
820-826
|
| 22.
|
Smale, S. T.,
Schmidt, M. C.,
Berk, A. J.,
and Baltimore, D.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4509-4513
|
| 23.
|
O'Reilly, D. R.,
Miller, L. K.,
and Luckow, V. A.
(1992)
Baculovirus Expression Vectors: A Laboratory Manual
, W. H. Freeman and Co., New York
|
| 24.
|
Hasnain, S. E.,
Habib, S.,
Jain, A.,
Burma, S.,
and Mukherjee, B.
(1996)
Methods Enzymol.
274,
20-32
|
| 25.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 26.
|
Hasnain, S. E.,
and Nakhai, B.
(1990)
Gene (Amst.)
91,
135-138
|
| 27.
|
Habib, S.,
Pandey, S.,
Chatterji, U.,
Burma, S.,
Ahmad, R.,
Jain, A.,
and Hasnain, S. E.
(1996)
DNA Cell Biol.
15,
737-747
|
| 28.
|
Habib, S.,
and Hasnain, S. E.
(1996)
J. Biol. Chem.
271,
28250-28258
|
| 29.
|
Maxam, A. M.,
and Gilbert, W.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
560-564
|
| 30.
|
Hasnain, S. E.,
Nakhai, B.,
Ehtesham, N. Z.,
Sridhar, P.,
Ranjan, A.,
Talwar, G. P.,
and Jha, P. K.
(1994)
DNA Cell Biol.
13,
275-282
|
| 31.
|
Sridhar, P.,
Awasthi, A. K.,
Azim, C. A.,
Burma, S.,
Habib, S.,
Jain, A.,
Mukherjee, B.,
Ranjan, A.,
and Hasnain, S. E.
(1994)
J. Biosci. (Bangalore)
19,
603-614
|
| 32.
|
Ham, J.,
Steger, G.,
and Yaniv, M.
(1994)
EMBO J.
13,
147-157
|
| 33.
|
Zenzie-Gregory, B.,
Khachi, A.,
Garuaway, I. P.,
and Smale, S. T.
(1993)
Mol. Cell. Biol.
13,
3841-3849
|
| 34.
|
Chalkley, G. E.,
and Peter Verrijzer, C.
(1999)
EMBO J.
18,
4835-4845
|
| 35.
|
Jones, K. A.,
Kadonaga, J. T.,
Luciw, P. A.,
and Tjian, R. T.
(1986)
Science
232,
575-759
|
| 36.
|
Kadonaga, J. T.,
Jones, K. A.,
and Tjian, R. T.
(1986)
Trends Biochem. Sci.
11,
20-23
|
| 37.
|
Hasnain, S. E.,
Jain, A.,
Habib, S.,
Ghosh, S.,
Chatterji, U.,
Ramachandran, A.,
Das, P.,
Venkaiah, B.,
Pandey, S.,
Liang, B.,
Ranjan, A.,
Natarajan, K.,
and Azim, C. A.
(1997)
Gene (Amst.)
190,
113-118
|
| 38.
|
Mukherjee, B.,
Burma, S.,
Talwar, G. P.,
and Hasnain, S. E.
(1995)
DNA Cell Biol.
14,
7-14
|
| 39.
|
Lu, A.,
and Miller, L. K.
(1995)
J. Virol.
69,
975-982
|
| 40.
|
Gearing, K. L.,
and Possee, R. D.
(1990)
J. Gen. Virol.
71,
251-262
|
| 41.
|
Dynan, W. S.,
and Tjian, R. T.
(1983)
Cell
32,
669-680
|
| 42.
|
Briggs, M. R.,
Kadonaga, J. T.,
Bell, S. P.,
and Tjian, R. T.
(1986)
Science
234,
47-52
|
| 43.
|
Zhang, S.,
Varma, A.,
and Williamson, P. T.
(1999)
Gene (Amst.)
227,
231-240
|
| 44.
|
Brönner, G.,
Chu-LaGraff, Q.,
Doe, C. Q.,
Cohen, B.,
Weigel, D.,
Taubert, H.,
and Jackle, H.
(1994)
Nature
369,
664-668
|
| 45.
|
Wimmer, E. A.,
Simpson-Brose, M.,
Cohen, S. M.,
Desplan, C.,
and Jackle, H.
(1995)
Mech. Dev.
53,
235-245
|
| 46.
|
Wimmer, E. A.,
Frömmer, G.,
Purnell, B. A.,
and Jackle, H.
(1996)
Mech. Dev.
59,
53-62
|
| 47.
|
Courey, A. J.,
and Tjian, R.
(1988)
Cell
55,
887-898
|
| 48.
|
Courey, A. J.,
Holtzman, D. A.,
Jackson, S. P.,
and Tjian, R.
(1989)
Cell
59,
827-836
|
| 49.
|
Hagen, G.,
Muller, S.,
Beato, M.,
and Suske, G.
(1992)
Nucleic Acids Res.
20,
5519-5525
|
| 50.
|
Hagen, G.,
Muller, S.,
Beato, M.,
and Suske, G.
(1994)
EMBO J.
13,
3843-3851
|
| 51.
|
Kingsley, C.,
and Winoto, A.
(1992)
Mol. Cell. Biol.
12,
4251-4261
|
| 52.
|
Maouche, L.,
Lucien, N.,
Cartron, J. P.,
and Chretien, S.
(1995)
Eur. J. Biochem.
233,
793-799
|
| 53.
|
Prowse, D. M.,
Bolgan, L.,
Molnar, A.,
and Paolo Dotto, G.
(1997)
J. Biol. Chem.
272,
1308-1314
|
| 54.
|
Tanese, N.,
Saluja, D.,
Vassallo, M. F.,
Chen, J.-L.,
and Admon, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13611-13616
|
| 55.
|
Hoey, T.,
Weinzierl, R. O.,
Gill, G.,
Chen, J.-L.,
Dynlacht, B. D.,
and Tjian, R.
(1993)
Cell
72,
247-260
|
| 56.
|
Krumm, A.,
Madisen, L.,
Yang, X.-J.,
Goodman, R.,
Nakatani, Y.,
and Groudine, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13501-13506
|
| 57.
|
Etkin, E.,
Carp-Weiss, L.,
and Levi, B.-Z.
(1994)
Virus Res.
31,
343-356
|
| 58.
|
Jain, A.,
and Hasnain, S. E.
(1996)
Eur. J. Biochem.
239,
384-390
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Aslanidi, K. Lamb, and S. Zolotukhin
An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells
PNAS,
March 31, 2009;
106(13):
5059 - 5064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stepanova, T. Tiazhelova, M. Skoblov, and A. Baranova
A comparative analysis of relative occurrence of transcription factor binding sites in vertebrate genomes and gene promoter areas
Bioinformatics,
May 1, 2005;
21(9):
1789 - 1796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Ropp, C. E. M. Wees, Y. Fang, E. A. Nelson, K. D. Rossow, M. Bien, B. Arndt, S. Preszler, P. Steen, J. Christopher-Hennings, et al.
Characterization of Emerging European-Like Porcine Reproductive and Respiratory Syndrome Virus Isolates in the United States
J. Virol.,
April 1, 2004;
78(7):
3684 - 3703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Viswanathan, B. Venkaiah, M. S. Kumar, S. Rasheedi, S. Vrati, M. D. Bashyam, and S. E. Hasnain
The Homologous Region Sequence (hr1) of Autographa californica Multinucleocapsid Polyhedrosis Virus Can Enhance Transcription from Non-baculoviral Promoters in Mammalian Cells
J. Biol. Chem.,
December 26, 2003;
278(52):
52564 - 52571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-R. Lo, C.-C. Chou, T.-Y. Wu, J. P.-Y. Yuen, and Y.-C. Chao
Novel Baculovirus DNA Elements Strongly Stimulate Activities of Exogenous and Endogenous Promoters
J. Biol. Chem.,
February 8, 2002;
277(7):
5256 - 5264.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|